65 related articles for article (PubMed ID: 18204205)
1. Standardization for transcriptomic molecular markers to screen human colon cancer.
Ahmed FE; Vos PW; Ijames S; Lysle DT; Flake G; Sinar DR; Naziri W; Marcuard SP
Cancer Genomics Proteomics; 2007; 4(6):419-31. PubMed ID: 18204205
[TBL] [Abstract][Full Text] [Related]
2. Transcriptomic molecular markers for screening human colon cancer in stool and tissue.
Ahmed FE; Vos P; iJames S; Lysle DT; Allison RR; Flake G; Sinar DR; Naziri W; Marcuard SP; Pennington R
Cancer Genomics Proteomics; 2007; 4(1):1-20. PubMed ID: 17726236
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle.
Ahmed FE; Ahmed NC; Vos PW; Bonnerup C; Atkins JN; Casey M; Nuovo GJ; Naziri W; Wiley JE; Mota H; Allison RR
Cancer Genomics Proteomics; 2013; 10(3):93-113. PubMed ID: 23741026
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic microRNA markers for screening sporadic human colon cancer and active ulcerative colitis in stool and tissue.
Ahmed FE; Jeffries CD; Vos PW; Flake G; Nuovo GJ; Sinar DR; Naziri W; Marcuard SP
Cancer Genomics Proteomics; 2009; 6(5):281-95. PubMed ID: 19996134
[TBL] [Abstract][Full Text] [Related]
5. Molecular markers for human colon cancer in stool and blood identified by RT-PCR.
Ahmed FE; Vos P
Anticancer Res; 2004; 24(6):4127-34. PubMed ID: 15736463
[TBL] [Abstract][Full Text] [Related]
6. Analysis of gene expression profile in colon cancer using the Cancer Genome Anatomy Project and RNA interference.
Huang ZG; Ran ZH; Lu W; Xiao SD
Chin J Dig Dis; 2006; 7(2):97-102. PubMed ID: 16643337
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic microRNA markers to screen for sporadic human colon cancer in blood.
Ahmed FE; Amed NC; Vos PW; Bonnerup C; Atkins JN; Casey M; Nuovo GJ; Naziri W; Wiley JE; Allison RR
Cancer Genomics Proteomics; 2012; 9(4):179-92. PubMed ID: 22798503
[TBL] [Abstract][Full Text] [Related]
8. miRNA as markers for the diagnostic screening of colon cancer.
Ahmed FE
Expert Rev Anticancer Ther; 2014 Apr; 14(4):463-85. PubMed ID: 24580550
[TBL] [Abstract][Full Text] [Related]
9. Improved methods for extracting RNA from exfoliated human colonocytes in stool and RT-PCR analysis.
Ahmed FE; James SI; Lysle DT; Dobbs LJ; Johnke RM; Flake G; Stockton P; Sinar DR; Naziri W; Evans MJ; Kovacs CJ; Allison RR
Dig Dis Sci; 2004; 49(11-12):1889-98. PubMed ID: 15628722
[TBL] [Abstract][Full Text] [Related]
10. Quantitative expression analysis and prognostic significance of the novel apoptosis-related gene BCL2L12 in colon cancer.
Kontos CK; Papadopoulos IN; Scorilas A
Biol Chem; 2008 Dec; 389(12):1467-75. PubMed ID: 18844453
[TBL] [Abstract][Full Text] [Related]
11. Expression profiling of fecal colonocytes for RNA-based screening of colorectal cancer.
Yajima S; Ishii M; Matsushita H; Aoyagi K; Yoshimatsu K; Kaneko H; Yamamoto N; Teramoto T; Yoshida T; Matsumura Y; Sasaki H
Int J Oncol; 2007 Nov; 31(5):1029-37. PubMed ID: 17912428
[TBL] [Abstract][Full Text] [Related]
12. A new method for isolating colonocytes from naturally evacuated feces and its clinical application to colorectal cancer diagnosis.
Matsushita H; Matsumura Y; Moriya Y; Akasu T; Fujita S; Yamamoto S; Onouchi S; Saito N; Sugito M; Ito M; Kozu T; Minowa T; Nomura S; Tsunoda H; Kakizoe T
Gastroenterology; 2005 Dec; 129(6):1918-27. PubMed ID: 16344060
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of carcinoembryonic antigen (CEA) splice variants in whole blood of colon cancer patients and healthy volunteers: implication for the detection of circulating colon cancer cells.
Hampton R; Walker M; Marshall J; Juhl H
Oncogene; 2002 Nov; 21(51):7817-23. PubMed ID: 12420218
[TBL] [Abstract][Full Text] [Related]
14. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
[TBL] [Abstract][Full Text] [Related]
15. Illumina whole-genome complementary DNA-mediated annealing, selection, extension and ligation platform: assessing its performance in formalin-fixed, paraffin-embedded samples and identifying invasion pattern-related genes in oral squamous cell carcinoma.
Loudig O; Brandwein-Gensler M; Kim RS; Lin J; Isayeva T; Liu C; Segall JE; Kenny PA; Prystowsky MB
Hum Pathol; 2011 Dec; 42(12):1911-22. PubMed ID: 21683979
[TBL] [Abstract][Full Text] [Related]
16. Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer.
Wang Y; Jatkoe T; Zhang Y; Mutch MG; Talantov D; Jiang J; McLeod HL; Atkins D
J Clin Oncol; 2004 May; 22(9):1564-71. PubMed ID: 15051756
[TBL] [Abstract][Full Text] [Related]
17. Equivalence test in quantitative reverse transcription polymerase chain reaction: confirmation of reference genes suitable for normalization.
Haller F; Kulle B; Schwager S; Gunawan B; von Heydebreck A; Sültmann H; Füzesi L
Anal Biochem; 2004 Dec; 335(1):1-9. PubMed ID: 15519565
[TBL] [Abstract][Full Text] [Related]
18. Bioinformatics-based discovery of a novel factor with apparent specificity to colon cancer.
De Young MP; Damania H; Scheurle D; Zylberberg C; Narayanan R
In Vivo; 2002; 16(4):239-48. PubMed ID: 12224133
[TBL] [Abstract][Full Text] [Related]
19. CIMP status of interval colon cancers: another piece to the puzzle.
Arain MA; Sawhney M; Sheikh S; Anway R; Thyagarajan B; Bond JH; Shaukat A
Am J Gastroenterol; 2010 May; 105(5):1189-95. PubMed ID: 20010923
[TBL] [Abstract][Full Text] [Related]
20. Prognostic and predictive potential molecular biomarkers in colon cancer.
Nastase A; Pâslaru L; Niculescu AM; Ionescu M; Dumitraşcu T; Herlea V; Dima S; Gheorghe C; Lazar V; Popescu I
Chirurgia (Bucur); 2011; 106(2):177-85. PubMed ID: 21696062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]